Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2018-07-04 2018-07-03
Drug Identification Number 02379120 02379120
Brand name MYLAN-CANDESARTAN MYLAN-CANDESARTAN
Common or Proper name CANDESARTAN CANDESARTAN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CANDESARTAN CILEXETIL CANDESARTAN CILEXETIL
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-07-03 2018-07-03
Actual discontinuation date 2018-07-03 2018-07-03
Remaining supply date 2018-07-03 2018-07-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in shortage ID 13190. Last lot 3065384 Expires 31-Mar-19 Discontinued in shortage ID 13190. Last lot 3065384 Expires 31-Mar-19
Health Canada comments